- Home
- BDRX vs SOBR Comparison
BDRX vs SOBR Comparison
Compare BDRX & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | SOBR |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BDRX | SOBR |
|---|---|---|
| Price | $2.14 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 981.2K | ★ 7.4M |
| Earning Date | 09-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $364,164.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 98.07 |
| 52 Week Low | $2.06 | $1.27 |
| 52 Week High | $92.00 | $14.20 |
Technical Indicators
Market Signals| Indicator | BDRX | SOBR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.11 |
| Support Level | N/A | $2.05 |
| Resistance Level | N/A | $2.40 |
| Average True Range (ATR) | 0.00 | 0.23 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 27.37 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.